Archives

Appen, BrainChip and Pro Medicus showcase three distinct approaches to AI on the ASX, spanning data services, neuromorphic chip design and healthcare software, highlighting varied business models and risk profiles.

• June 10, 2026 02:07 PM AEST
• Sam

Healthcare stocks are attracting attention as diagnostics, devices, product adoption, reimbursement settings and clinical evidence become key themes across the Australian healthcare sector.

• June 10, 2026 01:55 PM AEST
• Sam

ASX healthcare stocks are evaluated on commercial proof, revenue momentum, adoption, clinical evidence and operational execution as the sector moves from trial outcomes to validated market performance.

• June 10, 2026 01:55 PM AEST
• Sam

ASX healthcare stocks are assessed through valuation repair, revenue momentum, product adoption, clinical evidence, margin quality, and operational execution across CSL, ResMed, Cochlear, Pro Medicus, and Telix Pharmaceuticals.

• June 10, 2026 01:54 PM AEST
• Sam

ASX growth stocks attention focuses on recurring revenue, margin expansion, global runway, customer retention and operational discipline in 2026.

• June 10, 2026 01:53 PM AEST
• Sam

ASX growth stocks are under scrutiny for recurring revenue, margin expansion, customer retention, global platform exposure and post-reinvestment cash generation.

• June 10, 2026 01:53 PM AEST
• Sam

The technology and innovation segment of the Australian market is undergoing a notable shift in attention.

• June 10, 2026 01:53 PM AEST
• Sam

ASX gold stocks are now assessed through hedge books, production consistency, all-in sustaining costs, and balance-sheet strength as operational evidence becomes central to sector evaluation.

• June 10, 2026 01:42 PM AEST
• Sam

Gold stocks are being assessed in 2026 through the reserve replacement lens, with Northern Star (ASX:NST), Evolution (ASX:EVN), and Newmont (ASX:NEM) demonstrating operational and reserve-focused metrics that shape market attention across the [ASX 300].

• June 10, 2026 01:42 PM AEST
• Sam

ASX gold stocks in 2026 are assessed through cost inflation, focusing on operational margins, all-in sustaining costs, reserve life, production consistency, and hedge management across Northern Star, Evolution, and Newmont.

• June 10, 2026 01:42 PM AEST
• Sam